Daewon Pharmaceutical Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Seung-Ryel Baek

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer16.7yrs
Eigentum des Geschäftsführers15.9%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitgliederkeine Daten

Jüngste Management Updates

Recent updates

Daewon Pharmaceutical's (KRX:003220) Conservative Accounting Might Explain Soft Earnings

Nov 22
Daewon Pharmaceutical's (KRX:003220) Conservative Accounting Might Explain Soft Earnings

Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Aug 13
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) 27% Jump Shows Its Popularity With Investors

Jul 17
Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) 27% Jump Shows Its Popularity With Investors

There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings

Mar 21
There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings

Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Mar 26
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?

Mar 07
Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?

Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?

Feb 18
Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?

Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 31
Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?

Jan 13
Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?

Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Dec 24
Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly

Dec 10
Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly

Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?

Nov 22
Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?

Geschäftsführer

Seung-Ryel Baek (65 yo)

16.7yrs

Amtszeit

Mr. Seung-Ryel Baek serves as the Chief Executive Officer of Daewon Pharmaceutical Co. Ltd., and has also been its Director since March 14, 2008. Mr. Baek serves as President of Daewon Pharmaceutical Co. L...